Approvals/TGA/VARENAPIX 0.5 mg varenicline (as tartrate) tablets and 1.0 mg varenicline (as tartrate) tablets composite blister pack

Approved

STANDARD

VARENAPIX 0.5 mg varenicline (as tartrate) tablets and 1.0 mg varenicline (as tartrate) tablets composite blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cd959d2efd988cc0
Product Name: VARENAPIX 0.5 mg varenicline (as tartrate) tablets and 1.0 mg varenicline (as tartrate) tablets composite blister pack
Artg Id: 393491
Artg Name: VARENAPIX 0.5 mg varenicline (as tartrate) tablets and 1.0 mg varenicline (as tartrate) tablets composite blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2022-11-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/110b83d86b12692bdcf50d6ae04982d1.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1e1462a610c4f4ea51b535eb9ecfe48c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

cd959d2efd988cc0

Type

Standard